HomeNewsTrendsEntertainmentReeling under lockdown: Single screens face existential threat as big films release on OTT first

Reeling under lockdown: Single screens face existential threat as big films release on OTT first

Some single-screen cinemas have shut shop and many exhibitors are contemplating bringing the curtains down forever.

July 01, 2020 / 19:53 IST
Story continues below Advertisement
Representative image
Representative image

It’s a double whammy for cinema theatres. First, the coronavirus-led lockdown and theatres remaining shut for over 100 days with no sign of reopening yet. And now, star-studded films directly releasing on over-the-top (OTT) platforms.

The impact of both these aspects is felt more by single screens. Some of them have already shut and many single-screen exhibitors are contemplating bringing the curtains down forever.

Story continues below Advertisement

In the last few months, many single-screen theatres including Maharani and AVM Rajeswari in Chennai, and Shantala and Padma in Karnataka have permanently closed.

These were iconic single-screen properties that were entertaining Indian audiences for years. AVM Rajeswari was opened in 1979, Maharani in 1949, Shantala was a 46-year old theatre and Padma, which started 80 years back, was considered among the first-generation theatres.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show